Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Skin and self‐injury: a possible link between peripheral innervation and immune function?
Symons, Frank J. , Gilles, Elizabeth, Tervo, Raymond C., Wendelschafer‐Crabb, Gwen, Panoutsopoulou, Ioanna G., Tervo, Raymond, Kennedy, William R.

Developmental Medicine & Child Neurology | September 4, 2014 | Volume: 57 | Issue: 7 | Pages: 677-680

10.1111/dmcn.12580 | PMID 25185892 Get It

The aim of this preliminary case study series was to investigate epidermal innervation in pediatric patients with significant neurological impairment and self‐injurious behavior. We enrolled four pediatric patients with self‐injury (two males, two females; mean age 12y, range 9–14y) and used archival specimens from healthy, age‐matched children with typical development for comparison purposes. Epidermal nerve fiber density, peptide content, and mast cell degranulation patterns from non‐damaged skin were tested between the patients and the comparison group. The male patients with self‐injury had significantly increased epidermal nerve fiber densities, increased substance P positive fiber count and extensive mast cell degranulation compared with sex‐ and age‐matched individuals with typical development. Our case series shows for the first time altered peripheral innervation from non‐damaged tissue in children with significant self‐injury and developmental disability compared with a healthy comparison group. Establishing the role of peripheral nociceptive and immune modulatory neural pathways may offer new treatment avenues for this devastating neurobehavioral disorder.
Breaking Down Translation Barriers: Investigator’s Perspective
Staff, Nathan P. , Runge, Bethany Kinseth, Windebank, Anthony J. , Staff, Nathan P

Science Translational Medicine | September 4, 2014 | Volume: 6 | Issue: 252 | Pages: No page available

10.1126/scitranslmed.3008252 | PMID 25186172 Get It

Biomedical scientists can exploit initiatives from U.S. federal regulatory and funding agencies aimed at accelerating clinical translation.
Carotid Stump Syndrome
Dakhoul, Lara , Tawk, Rabih, Tawk, Rabih G.

Journal of Investigative Medicine High Impact Case Reports | September 4, 2014 | Volume: 2 | Issue: 3 | Pages: No page available

10.1177/2324709614548796 | PMID 26425620 Get It

Objectives. To highlight the case of a patient with multiple transient ischemic attacks and visual disturbances diagnosed with carotid stump syndrome and managed with endovascular approach. Case Presentation. We present the case of a carotid stump syndrome in an elderly patient found to have moderate left internal carotid artery stenosis in response to an advertisement for carotid screening. After a medical therapeutic approach and a close follow-up, transient ischemic attacks recurred. Computed tomographic angiography showed an occlusion of the left internal carotid artery and the presence of moderate stenosis in the right internal carotid artery, which was treated by endovascular stenting and balloon insertion. One month later, the patient presented with visual disturbances due to the left carotid stump and severe stenosis of the left external carotid artery that was reapproached by endovascular stenting. Conclusion. Considerations should be given to the carotid stump syndrome as a source of emboli for ischemic strokes, and vascular assessment could be used to detect and treat this syndrome.
Kidney: polycystic kidney disease
Paul, Binu M., Heuvel, Gregory B. Vanden

WIREs Developmental Biology | September 3, 2014 | Volume: 3 | Issue: 6 | Pages: 465-487

10.1002/wdev.152 | PMID 25186187 Get It

Polycystic kidney disease (PKD) is a life‐threatening genetic disorder characterized by the presence of fluid‐filled cysts primarily in the kidneys. PKD can be inherited as autosomal recessive (ARPKD) or autosomal dominant (ADPKD) traits. Mutations in either the PKD1 or PKD2 genes, which encode polycystin 1 and polycystin 2, are the underlying cause of ADPKD. Progressive cyst formation and renal enlargement lead to renal insufficiency in these patients, which need to be managed by lifelong dialysis or renal transplantation. While characteristic features of PKD are abnormalities in epithelial cell proliferation, fluid secretion, extracellular matrix and differentiation, the molecular mechanisms underlying these events are not understood. Here we review the progress that has been made in defining the function of the polycystins, and how disruption of these functions may be involved in cystogenesis. WIREs Dev Biol 2014, 3:465–487. doi: 10.1002/wdev.152This article is categorized under: Signaling Pathways > Global Signaling Mechanisms Birth Defects > Organ Anomalies
Selective Assembly of DNA-Conjugated Single-Walled Carbon Nanotubes from the Vascular Secretome
Gong, Xun , Sharma, Anil Kumar , Strano, Michael S. , Sharma, Anil K. , Mukhopadhyay, Debabrata , Gong, Xun

ACS Nano | September 3, 2014 | Volume: 8 | Issue: 9 | Pages: 9126-9136

10.1021/nn5026912 | PMID 25184956 Get It

Abstract Colloidal dispersion of single-walled carbon nanotubes (SWCNTs) is often the first processing step to many of their unique applications. However, dispersed SWCNTs often exist in kinetically trapped states where aggregation can be of concern. Recent work revealed prominent DNA–SWCNT aggregation following intravascular injection. In this study, we performed detailed analysis of DNA–SWCNT aggregate formation, structure, and composition in the context of endothelial cell condition media. Interestingly, we found that aggregates formed within condition media from cells that have undergone a stress response differ in size and organization from that of the control. We also found that temperature increases also promote DNA–SWCNT associations. A mathematical model was developed to describe the kinetics of SWCNT extraction from solution. Through orthogonal optical analysis and imaging modalities, we verified that proteins form the bulk of the aggregate structure and dictate aggregate assembly at multiple levels of organization. Finally, physiochemical analysis indicated preferential extraction of low-abundance hydrophobic and charged proteins. The formed aggregates also remain relatively stable in solution, making them potential macroscopic indicators of solution content.
Faculty Opinions recommendation of Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
Brodsky, Michael C., Grigorian, Paula

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 3, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718538551.793498969 Get It

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
Chawla, Sant P. , Cranmer, Lee D. , Reed, Damon R. , Okuno, Scott H. , Butrynski, James E., Hendifar, Andrew , Kroll, Stew, Ganjoo, Kristen N. , Van Tine, Brian A, Adkins, Douglas R. , Tine, Brian A. Van , Reed, Damon R

Journal of Clinical Oncology | September 3, 2014 | Volume: 32 | Issue: 29 | Pages: 3299-3306

10.1200/jco.2013.54.3660 | PMID 25185097 Get It

Purpose TH-302, a prodrug of the cytotoxic alkylating agent bromo-isophosphoramide mustard, is preferentially activated in hypoxic conditions. This phase II study investigated TH-302 in combination with doxorubicin, followed by single-agent TH-302 maintenance therapy in patients with first-line advanced soft tissue sarcoma (STS) to assess progression-free survival (PFS), response rate, overall survival, safety, and tolerability. Patients and Methods In this open-label phase II study, TH-302 300 mg/m 2 was administered intravenously on days 1 and 8 with doxorubicin 75 mg/m 2 on day 1 of each 21-day cycle. After six cycles, patients with stable and/or responding disease could receive maintenance monotherapy with TH-302. Results Ninety-one patients initiated TH-302 plus doxorubicin induction treatment. The PFS rate at 6 months (primary efficacy measure) was 58% (95% CI, 46% to 68%). Median PFS was 6.5 months (95% CI, 5.8 to 7.7 months); median overall survival was 21.5 months (95% CI, 16.0 to 26.2 months). Best tumor responses were complete response (n = 2 [2%]) and partial response (n = 30 [34%]). During TH-302 maintenance (n = 48), five patients improved from stable disease to partial response, and one patient improved from partial to complete response. The most common adverse events during induction were fatigue, nausea, and skin and/or mucosal toxicities as well as anemia, thrombocytopenia, and neutropenia. These were less severe and less frequent during maintenance. There was no evidence of TH-302–related hepatic, renal, or cardiac toxicity. Conclusion PFS, overall survival, and tumor response compared favorably with historical outcomes achieved with other first-line chemotherapies for advanced STS. A phase III study of TH-302 is ongoing (NCT01440088).
Motor unit number estimation: A technology and literature review
Gooch, Clifton L. , Doherty, Timothy J., Chan, K. Ming , Bromberg, Mark B. , Lewis, Richard A. , Stashuk, Dan, Berger, Michael , Andary, Michael , Daube, Jasper R.

Muscle & Nerve | September 3, 2014 | Volume: 50 | Issue: 6 | Pages: 884-893

10.1002/mus.24442 | PMID 25186553 Get It

ABSTRACTIntroduction: Numerous methods for motor unit number estimation (MUNE) have been developed. The objective of this article is to summarize and compare the major methods and the available data regarding their reproducibility, validity, application, refinement, and utility.Methods: Using specified search criteria, a systematic review of the literature was performed. Reproducibility, normative data, application to specific diseases and conditions, technical refinements, and practicality were compiled into a comprehensive database and analyzed.Results: The most commonly reported MUNE methods are the incremental, multiple‐point stimulation, spike‐triggered averaging, and statistical methods. All have established normative data sets and high reproducibility. MUNE provides quantitative assessments of motor neuron loss and has been applied successfully to the study of many clinical conditions, including amyotrophic lateral sclerosis and normal aging.Conclusions: MUNE is an important research technique in human subjects, providing important data regarding motor unit populations and motor unit loss over time.Muscle Nerve50: 884–893, 2014
Author's Response
Absah, Imad

Journal of Pediatric Gastroenterology and Nutrition | September 3, 2014 | Volume: 59 | Issue: 6 | Pages: No page available

10.1097/mpg.0000000000000551 | PMID 25187108 Get It

Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism
Appel‐Cresswell, Silke , Rajput, Ali H. , Thompson, Christina, Silva, Vanessa , McKenzie, Jessamyn , Dinelle, Katherine, McCormick, Siobhan, Vilariño‐Güell, Carles , Stoessl, A. Jon , Dickson, Dennis W. , Robinson, Chris , Farrer, Matthew J. , Rajput, Alex, Sossi, Vesna , Dickson, Dennis W , Appel-Cresswell, Silke

Movement Disorders | September 3, 2014 | Volume: 29 | Issue: 13 | Pages: 1684-1687

10.1002/mds.26019 | PMID 25186792 Get It

AbstractBackgroundFamilies of Dutch‐German‐Russian Mennonite descent with multi‐incident parkinsonism have been identified as harboring a pathogenic DNAJC13 p.N855S mutation and are awaiting clinical and pathophysiological characterization.MethodsFamily members were examined clinically longitudinally, and 5 underwent dopaminergic PET imaging. Four family members came to autopsy.ResultsOf the 16 symptomatic DNAJC13 mutation carriers, 12 had clinically definite, 3 probable, and 1 possible Parkinson's disease (PD). Symptoms included bradykinesia, tremor, rigidity, and postural instability, with a mean onset of 63 years (range, 40‐85) and slow progression. Eight of ten subjects who required treatment had a good levodopa response; motor complications and nonmotor symptoms were observed. Dopaminergic PET imaging revealed rostrocaudal striatal deficits typical for idiopathic PD in established disease and subtle abnormalities in incipient disease. Pathological examinations revealed Lewy body pathology.ConclusionPD associated with a DNAJC13 p.N855S mutation presents as late‐onset, often slowly progressive, usually dopamine‐responsive typical PD. © 2014 International Parkinson and Movement Disorder Society